Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.6%

7 terminated out of 66 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

20%

13 trials in Phase 3/4

Results Transparency

33%

7 of 21 completed with results

Key Signals

7 with results75% success

Data Visualizations

Phase Distribution

40Total
Not Applicable (11)
Early P 1 (2)
P 1 (4)
P 2 (10)
P 3 (5)
P 4 (8)

Trial Status

Completed21
Unknown16
Recruiting11
Not Yet Recruiting8
Terminated7
Withdrawn2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (66)

Showing 20 of 20 trials
NCT07720245Not ApplicableRecruiting

Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong

NCT02344680Completed

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

NCT06834178RecruitingPrimary

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

NCT03158818CompletedPrimary

Chronic Hepatitis B Virus Infection in Zambia

NCT04904835CompletedPrimary

Access HBV Assays - European Union (EU) Clinical Trial Protocol -

NCT07529171RecruitingPrimary

HBV Reactivation in Immunocompromised Patients (REANT STUDY)

NCT07429864RecruitingPrimary

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

NCT07170748Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

NCT03149627CompletedPrimary

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

NCT06372990RecruitingPrimary

Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease

NCT06671093Phase 1Recruiting

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

NCT07231276Phase 4Not Yet RecruitingPrimary

Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B

NCT04942886Not ApplicableEnrolling By Invitation

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

NCT07007286Not Yet RecruitingPrimary

Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

NCT06926647Not Yet RecruitingPrimary

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

NCT06746701RecruitingPrimary

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

NCT02836249Phase 3CompletedPrimary

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

NCT02836236Phase 3CompletedPrimary

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

NCT06579313Not Yet RecruitingPrimary

Current Situation of Health Care in Women With HBV or HCV Infection

NCT06503796Phase 4Not Yet RecruitingPrimary

Antiviral Therapy in Infants With HBV Infection

Scroll to load more

Research Network

Activity Timeline